BPG is committed to discovery and dissemination of knowledge
Correspondence Open Access
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2026; 32(30): 116606
Published online Aug 14, 2026. doi: 10.3748/wjg.116606
Letter to the Editor: Omission of key predictors of sepsis undermines the validity of risk modelling for post-endoscopic retrograde cholangiopancreatography biliary infection
Omar Elshaarawy, Jayapal Ramesh, Department of Gastroenterology, University of Liverpool Hospitals, Liverpool L7 8YE, Merseyside, United Kingdom
Jayapal Ramesh, Centre for Advanced Endoscopy Research and Education, Orlando Health Digestive Health Institute, Orlando, FL 32806, United States
ORCID number: Omar Elshaarawy (0000-0002-6945-6204); Jayapal Ramesh (0000-0001-6573-1371).
Co-corresponding authors: Omar Elshaarawy and Jayapal Ramesh.
Author contributions: Elshaarawy O and Ramesh J conceived and designed the manuscript; Elshaarawy O drafted the manuscript; Ramesh J critically revised the manuscript for important intellectual content.
AI contribution statement: Grammarly for language polishing of Abstract. The authors confirm that no AI tools were used for study design, analysis, image generation or data interpretation. Grammarly was only used for language polishing of the abstract to ensure clarity.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Omar Elshaarawy, MD, Doctor, Department of Gastroenterology, University of Liverpool Hospitals, Mount Vernon Street, Liverpool L7 8YE, Merseyside, United Kingdom. oelshaarawy@outlook.com
Received: November 17, 2025
Revised: January 18, 2026
Accepted: February 26, 2026
Published online: August 14, 2026
Processing time: 250 Days and 4.4 Hours

Abstract

Post-endoscopic retrograde cholangiopancreatography biliary infection remains a significant cause of morbidity in malignant perihilar biliary obstruction. A recent model by Wang et al, published in the recent issue of the World Journal of Gastroenterology, which identified hypokalaemia, Bismuth-Corlette classification, and aspartate aminotransferase as predictors, yet omitted critical sepsis determinants. The absence of key variables, including baseline inflammatory biomarkers, biliary colonization, stent characteristics, antibiotic protocols, and particularly the degree of biliary drainage, such as hepatic volume decompressed and undrained ducts after failed cannulation, significantly limits validity. Drainage adequacy is central to infection pathogenesis and outcome. Comprehensive models incorporating these parameters are essential for accurate risk prediction and meaningful clinical application.

Key Words: Endoscopic retrograde cholangiopancreatography; Infection; Drainage; Sepsis; Stents; Biliary; Ducts

Core Tip: Post-endoscopic retrograde cholangiopancreatography biliary infection is a significant risk in malignant obstruction. Current risk models are incomplete, omitting critical factors like drainage adequacy (hepatic volume decompressed) and inflammatory biomarkers. Comprehensive models are essential for accurate postoperative biliary infection risk prediction and better clinical outcomes.



TO THE EDITOR

We read with great interest the recent multicentre retrospective study by Wang et al[1] published in the World Journal of Gastroenterology. The authors should be commended for applying both logistic regression and artificial neural network (ANN) approaches to predict postoperative biliary infection (PBI) following endoscopic retrograde cholangiopancreatography (ERCP) in malignant perihilar biliary obstruction (MPHBO). However, we want to raise a key methodological concern that may undermine the predictive validity and generalizability of the model. The variables evaluated Bismuth Corlette classification, hypokalaemia and aspartate aminotransferase although statistically significant, miss one of the most established determinants of post ERCP sepsis which is adequacy of biliary drainage. This omission poses a particular problem in ANN-based prediction because ANNs are very sensitive to variable selection. The omission of mechanism predominant predictors like drainage adequacy will disproportionately invalidate the model by compelling the network to learn incomplete causal pathways. The amount of hepatic volume to which decompression is successfully achieved, the proportion of undrained ducts, and the technical success of cannulation are the factors that directly determine biliary sterility and risk of infection. The adequacy of drainage must be measured in objective terms such as: (1) The amount of liver mass that was drained (preferably ≥ 50 of total hepatic volume); (2) Whether one or both sides was drained in lesions of the Bismuth type III-IV; and (3) Any remaining undrained hepatic mass should be reported after the operation.

Kühl et al[2], in finding the main factor in determining infectious sequelae following ERCP, demonstrated that patients with residual obstruction had significantly increased rates of cholangitis and bacteremia. Similar results were drawn by Tarnasky and Kedia[3] who found that the key predictive factor of post-ERCP cholangitis is incomplete biliary drainage, and the central modifiable factor that determines the outcome of infections is the adequacy of the procedures. Decades ago, Deviere et al[4] showed that septicaemia after endoscopic internal drainage of hilar malignant strictures was associated with undrained intrahepatic ducts and partial decompression. Additional important determinants that were not included in the analysis are stent characteristics (type and size), and underlying aetiology. Self-expandable metal stents provide superior patency and reduced rates of stent occlusion and cholangitis compared with plastic stents in malignant obstruction and larger or multiple stents enhance time to dysfunction; conversely, small-diameter plastic stents have higher reintervention rates factors that materially affect post-procedural infectious risk and need to be included in predictive models[5-7]. Moreover, the type of primary tumor (cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma, or metastatic disease) affects the ductal anatomy, the probability of multifocal obstruction, the response to biliary decompression and stent patency thereafter, all of which affect the risk of infection and clinical outcome[2,3,7].

The extent of these parameters relating to drainage is limited, and the modelling is restricted from matching the recommendations of the Tokyo Guidelines 2018, which emphasize complete biliary decompression as the cornerstone of sepsis prevention[8]. Such critical procedural data are likely to be omitted in the environment of MPHBO where the biochemical factors are inadvertently overstressed due to the exclusion of anatomical complexity in many cases.

In the future, predictive models should thus incorporate objective measures of biliary drainage sufficiency, hepatic volume decompressed, and remnant obstruction to enhance the mechanistic validity of clinical application of PBI risk prediction. This will ensure that the models are more realistic in terms of the procedural determinants of the infection in the real-world and enable risk-adjusted intervention planning that is evidence-based.

References
1.  Wang YF, Han K, An N, Sun YN, Gao F, Sun Y, Zhang D, Zhao ZF, Guo Q, Gu JN, Yang Z. Risk prediction of biliary infection after endoscopic drainage for malignant perihilar biliary obstruction: A 10-year multicenter retrospective study. World J Gastroenterol. 2025;31:113156.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Reference Citation Analysis (1)]
2.  Kühl N, Vollenberg R, Meier JA, Ullerich H, Schulz MS, Rennebaum F, Laleman W, Froböse NJ, Praktiknjo M, Peiffer K, Fischer J, Trebicka J, Gu W, Tepasse PR. Risk Factors for Infectious Complications following Endoscopic Retrograde Cholangiopancreatography in Liver Transplant Patients: A Single-Center Study. J Clin Med. 2024;13:1438.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
3.  Tarnasky PR, Kedia P. Endoscopic retrograde cholangiopancreatography complications: Techniques to reduce risk and management strategies. Int J Gastrointest Interv. 2017;6:37-53.  [PubMed]  [DOI]  [Full Text]
4.  Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc. 1988;34:95-101.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 245]  [Cited by in RCA: 204]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
5.  Song TJ, Lee JH, Lee SS, Jang JW, Kim JW, Ok TJ, Oh DW, Park DH, Seo DW, Lee SK, Kim MH, Kim SC, Kim CN, Yun SC. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection. Gastrointest Endosc. 2016;84:814-821.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 66]  [Cited by in RCA: 58]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
6.  Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy. World J Gastroenterol. 2016;22:6065-6075.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in CrossRef: 19]  [Cited by in RCA: 22]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
7.  Sharma BC, Agarwal N, Sharma P, Sarin SK. Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis. Dig Dis Sci. 2009;54:1355-1359.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 11]  [Cited by in RCA: 10]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
8.  Mayumi T, Okamoto K, Takada T, Strasberg SM, Solomkin JS, Schlossberg D, Pitt HA, Yoshida M, Gomi H, Miura F, Garden OJ, Kiriyama S, Yokoe M, Endo I, Asbun HJ, Iwashita Y, Hibi T, Umezawa A, Suzuki K, Itoi T, Hata J, Han HS, Hwang TL, Dervenis C, Asai K, Mori Y, Huang WS, Belli G, Mukai S, Jagannath P, Cherqui D, Kozaka K, Baron TH, de Santibañes E, Higuchi R, Wada K, Gouma DJ, Deziel DJ, Liau KH, Wakabayashi G, Padbury R, Jonas E, Supe AN, Singh H, Gabata T, Chan ACW, Lau WY, Fan ST, Chen MF, Ker CG, Yoon YS, Choi IS, Kim MH, Yoon DS, Kitano S, Inomata M, Hirata K, Inui K, Sumiyama Y, Yamamoto M. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:96-100.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 216]  [Cited by in RCA: 193]  [Article Influence: 24.1]  [Reference Citation Analysis (4)]
Footnotes

Peer review: Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: United Kingdom

Peer-review report’s classification

Scientific quality: Grade B, Grade B

Novelty: Grade B, Grade C

Creativity or innovation: Grade B, Grade C

Scientific significance: Grade A, Grade B

P-Reviewer: Hashimoto Y, Associate Professor, United States; Sheshala K, Consultant, Head, India S-Editor: Fan M L-Editor: A P-Editor: Wang CH

Write to the Help Desk